JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2005; 46:1827-1832, doi:10.1016/j.jacc.2005.07.056 (Published online 18 October 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (118)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gurbel, P. A.
Right arrow Articles by Tantry, U. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gurbel, P. A.
Right arrow Articles by Tantry, U. S.

Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis

Results of the CREST Study

Paul A. Gurbel, MD, FACC*, Kevin P. Bliden, BS, Waiel Samara, MD, Jason A. Yoho, MD, Kevin Hayes, MD, Mulugeta Z. Fissha, MD and Udaya S. Tantry, PhD

Sinai Center for Thrombosis Research, Baltimore, Maryland.



View larger version (14K):

[in a new window]
  		Figure 1 (A) 5 µmol/l adenosine diphosphate (ADP)-induced platelet aggregation in patients with stent thrombosis (SAT) and without stent thrombosis (No SAT). Dashed line indicates 75th percentile in non-SAT group. (B) 20 µmol/l ADP-induced platelet aggregation in patients with and without SAT. Dashed line = 75th percentile in non-SAT group.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.